Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks - Michael Migden, MD; Carmen Loquai, MD, PhD; Caroline Robert, MD, PhD; Jean-François Baurain, MD, PhD; Nicholas Squittieri, MD; Ramon Arntz, Dr; Jörg Dierlamm, BSc; Brigitte Dréno, MD, PhD (Elsevier, 2023)